terazosin

Generic: terazosin hydrochloride

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler avkare
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-821
Product ID 42291-821_3a9ec205-cdb5-e131-e063-6294a90acb60
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2020-03-30

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291821
Hyphenated Format 42291-821

Supplemental Identifiers

RxCUI
260376 313215 313217 313219
UPC
0342291823105 0342291820104 0342291821101
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 1000 CAPSULE in 1 BOTTLE (42291-821-10)
source: ndc

Packages (1)

42291-821-10 1000 CAPSULE in 1 BOTTLE (42291-821-10)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a9ec205-cdb5-e131-e063-6294a90acb60", "openfda": {"upc": ["0342291823105", "0342291820104", "0342291821101"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["a2137488-8554-e84f-e053-2995a90a796c"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (42291-821-10)", "package_ndc": "42291-821-10", "marketing_start_date": "20200330"}], "brand_name": "Terazosin", "product_id": "42291-821_3a9ec205-cdb5-e131-e063-6294a90acb60", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "42291-821", "generic_name": "Terazosin Hydrochloride", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20200330", "listing_expiration_date": "20261231"}